Results 171 to 180 of about 662,429 (302)

Predictive value of CD44 in membranous nephropathy with focal segmental glomerular sclerosis lesions treated with calcineurin inhibitors. [PDF]

Ren Fail
He HG, Huang YY, Ye K, Lu QM, Liang QQ, Ye QR, Wu QX, You YW.   +7 more
europepmc   +1 more source

Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China. [PDF]

Ren Fail, 2023
He HG, Huang YY, Liang QQ, Ye QR, Li AD, Ye K, Wu QX, You YW.   +7 more
europepmc   +1 more source

Trust in skincare and topical therapies in atopic dermatitis or psoriasis: a German cross‐sectional study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Trust in therapy impacts adherence and satisfaction in chronic inflammatory skin diseases, including atopic dermatitis (AD) and psoriasis (PSO). This study assessed and compared trust in skincare and topical therapies and explored influencing factors among AD and PSO patients.
Svenja Royeck, Anna Daphne Bamidis, Conrad Weckbecker, Silke C. Hofmann, Sonja Ständer, Stefan W Schneider, Angelika Weigel, Natalija Novak, Dagmar Wilsmann‐Theis, Galina Balakirski   +9 more
wiley   +1 more source

The treatment based on calcineurin inhibitors and their conversion to sirolimus alter the morphology in the rat testis. [PDF]

Sci Rep
Grabowska M, Michałek K, Kędzierska-Kapuza K, Gill K, Piasecka M.   +4 more
europepmc   +1 more source

Calcineurin inhibitors in systemic sclerosis - a systematic literature review. [PDF]

Ther Adv Musculoskelet Dis, 2022
Hofmann NN, Ambühl RA, Jordan S, Distler O.   +3 more
europepmc   +1 more source

Out‐of‐pocket costs and time spent on disease management by vitiligo patients: a cross‐sectional questionnaire study in German‐speaking countries

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives The financial and time‐related burden of patients with vitiligo remains insufficiently studied. This study aimed to quantify out‐of‐pocket costs (OOPC) and time expenditure for vitiligo management and the associated sociodemographic, clinical, and behavioral factors in German‐speaking countries.
Christine Gasteiger, Michael Hindelang, Stefanie Ziehfreund, Hannah Wecker, Tilo Biedermann, Alexander Zink   +5 more
wiley   +1 more source

Investigation of Renal Tissue Deposition of the Calcineurin Inhibitors Voclosporin, Cyclosporine and Tacrolimus Using MALDI-MSI Imaging. [PDF]

Pharm Res
Zhou S, Rajanayake KK, He M, Wen B, Lkhagva A, Yap E, Sun D, Cross J, Engelke K, Huizinga RB.   +9 more
europepmc   +1 more source

Early cessation of calcineurin inhibitors is feasible post-haploidentical blood stem cell transplant: the ANZHIT 1 study. [PDF]

Blood Adv, 2023
Moore J, Hamad N, Gottlieb D, Bajel A, Ritchie D, Yeung D, Greenwood M, Purtill D, Tran S, Solterbeck A, Aarons D, Kwan J.   +11 more
europepmc   +1 more source

HIV‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise

HIV Medicine, EarlyView.
Abstract Objective To review the pathogenesis, epidemiology, clinical presentation, management and outcomes of HIV‐associated nephropathy (HIVAN), with emphasis on global disparities, genetic susceptibility (APOL1) and emerging therapeutic and technological advances.
Deepak V. Pathiyil, Nicola Wearne, Brendon Price, Frank Post, Dami A. Collier   +4 more
wiley   +1 more source

Evaluating calcineurin inhibitors as alternatives to steroids in treating Oral Lichen Planus: a systematic review and meta-analysis. [PDF]

Front Oral Health
Sárai BZ, Gutmacher E, Cavalcante BGN, Kelemen K, Gede N, Hegyi P, Tábi D, Németh Z, Lohinai ZM, Varga G, Németh O.   +10 more
europepmc   +1 more source